Antivirals
35 Employers in 99 locations
35 Employers in 99 locations
Employers working on Antivirals work in 33 other areas
Displaying 1 - 15 of 33 related areas- Small Molecules (9)
- COVID-19 (8)
- Therapeutics (8)
- Cancer Therapeutics (4)
- Antibodies (3)
- Immunotherapy (3)
- Vaccines (3)
- Cell and Gene Therapy (2)
- Drug Delivery (2)
- Inflammation (2)
- Liver Disease (2)
- Peptides (2)
- Pharmaceuticals (2)
- Antibody-Drug Conjugates (1)
Displaying 1 - 35 of 35 employers
Only three business areas are listed for each employer.Business Area(s)
Description
Abacus Bioscience is developing novel immunotherapeutic treatments for managing ...
Business Area(s)
Description
viral reagent products, infectious disease antigens, and electron microscopy ...
Business Area(s)
Description
Developing Drugs to Treat Respiratory Viruses and Global Viral Threats
Business Area(s)
Description
Apriori was founded by Flagship Pioneering to provide humanity with variant ...
Business Area(s)
Description
Arbutus Biopharma Corporation ( NASDAQ: ABUS) is a publicly-traded ...
Business Area(s)
Description
Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock ...
Business Area(s)
Description
Assembly Biosciences is advancing a new class of oral therapeutics for the ...
Business Area(s)
Description
Atara Bio’s programs include T-cell product candidates and molecularly-targeted ...
Business Area(s)
Description
Atea is a clinical stage biopharmaceutical company working to address unmet ...
Business Area(s)
Description
Autonomous Therapeutics is developing Encrypted RNA™, a new class of RNA that ...
Business Area(s)
Description
Bluejay Therapeutics, Inc. is a private biopharmaceutical company developing ...
Business Area(s)
Description
Chimerix is developing medicines designed to protect immunocompromised patients ...
Business Area(s)
Description
Clear Creek Bio is a clinical-stage biotech developing oral antivirals. The ...
Business Area(s)
Description
Structure-Based Drug Discovery for Viral Replication Inhibitors
Business Area(s)
Description
ContraVir is developing a portfolio of novel compounds against hepatitis B ...
Business Area(s)
Description
CYGNOS is developing a propriety antiviral therapeutic peptide technology to ...
Business Area(s)
Description
Decoy Therapeutics is engineering broad acting antiviral drugs.
Business Area(s)
Description
ENA Respiratory is a clinical stage pharmaceutical company, developing INNA-051 ...
Business Area(s)
Description
Develops gene editing therapeutics for life threatening viral-related diseases. ...
Business Area(s)
Description
Research and development programs currently focus on potential treatments in HIV ...
Business Area(s)
Description
GlaxoSmithKline is a science-led global healthcare company with 3 global ...
Business Area(s)
Description
Huahui Health is a clinical-stage biopharmaceutical company focused on ...
Business Area(s)
Description
Mercury Bio is specializing in intracellular, targeted drug delivery systems for ...
Business Area(s)
Description
MetrioPharm AG is a pharmaceutical development company focusing on therapies for ...
Business Area(s)
Description
NanoViricides, Inc. makes nanoviricides®. Nanoviricides are nanoparticles ...
Business Area(s)
Description
Red Queen Therapeutics is a clinical-stage company working to deliver important ...
Business Area(s)
Description
DNA, polymer, small molecule combination Hepatitis B treatment
Business Area(s)
Description
Antiviral Drugs Development, Antiviral Assay Services
Business Area(s)
Description
Shionogi Inc. is the U.S. subsidiary of a 141-year-old global pharmaceutical ...
Business Area(s)
Description
Sun Pharma produces a comprehensive, diverse and highly complementary portfolio ...
Business Area(s)
Description
Virios Therapeutics (Nasdaq: VIRI) is a development-stage biotechnology company ...